Het Zaans Medisch Centrum is een algemeen ziekenhuis in de Nederlandse stad Zaandam. Het is een regionaal ziekenhuis met een overwegende oriëntatie op de Zaanstreek en omringende gebieden.

During the past decade, Zaans Medisch Centrum conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zaans Medisch Centrum" #1 sponsor was "Radboud University Medical Center" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Borstkanker Onderzoek Groep" with 2 trials sponsored, "Dutch Colorectal Cancer Group" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zaans Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Borstkanker Onderzoek Groep" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Zaans Medisch Centrum" are "Breast Cancer" (3 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Neoplasms" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Zaans Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Zaans Medisch Centrum" are "Drug" (18 trials), "Other" (8 trials), "Procedure" (5 trials), "Device" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials), "Empagliflozin" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zaans Medisch Centrum" are 25 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Zaans Medisch Centrum". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Zaans Medisch Centrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zaans Medisch Centrum, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".